Article By:
Rod Raynovich
Sunday, February 5, 2023 8:10 PM EDT
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
In this article: NTLA, IBB, PACB, XBI, SUPN, CRSP, ARKG, VCYT Also: CYRX, GERN, QDEL, HOLX, VRTX, EXAS, EVH, NVTA, TDOC
Exact Sciences: Poised For Further Growth
Great article! Analyst consensus = strong buy with $90 price target. $PFE $EXAS
Exact Sciences: Poised For Further Growth
Article is a good summary and is likely representative of the future for $EXAS.